Sometimes, mutations in the EGFR gene cause EGFR proteins to be made in higher than normal amounts in a number of cancer cell lines, including those from breast, colon, non-small cell lung, renal, melanoma, ovarian, and prostate cancers. This evidence concerns the gene EGFR and prostate carcinoma.